Market RealistA Deeper Look at Atara Biotherapeutics’ ATA129, ATA520, and ATA230Read full articleKenneth SmithUpdated February 1, 2018 at 7:34 a.m.A Deeper Look at Atara Biotherapeutics’ ATA129, ATA520, and ATA230Atara Biotherapeutics Today: Gauging Investor Interest in ATRAContinue reading